214 related articles for article (PubMed ID: 30721649)
21. Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer.
Giannone G; Tuninetti V; Ghisoni E; Genta S; Scotto G; Mittica G; Valabrega G
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083638
[TBL] [Abstract][Full Text] [Related]
22. The history and future of targeting cyclin-dependent kinases in cancer therapy.
Asghar U; Witkiewicz AK; Turner NC; Knudsen ES
Nat Rev Drug Discov; 2015 Feb; 14(2):130-46. PubMed ID: 25633797
[TBL] [Abstract][Full Text] [Related]
23. Temporal patterns of gene expression of G1-S cyclins and cdks during the first and second mitotic cell cycles in mouse embryos.
Moore GD; Ayabe T; Kopf GS; Schultz RM
Mol Reprod Dev; 1996 Nov; 45(3):264-75. PubMed ID: 8916036
[TBL] [Abstract][Full Text] [Related]
24. Cyclins and related kinases in cancer cells.
Malumbres M
J BUON; 2007 Sep; 12 Suppl 1():S45-52. PubMed ID: 17935277
[TBL] [Abstract][Full Text] [Related]
25. ATP-noncompetitive inhibitors of CDK-cyclin complexes.
Orzáez M; Gortat A; Mondragón L; Bachs O; Pérez-Payá E
ChemMedChem; 2009 Jan; 4(1):19-24. PubMed ID: 19039815
[TBL] [Abstract][Full Text] [Related]
26. Cell Cycle Regulation in Treatment of Breast Cancer.
Cai Z; Liu Q
Adv Exp Med Biol; 2017; 1026():251-270. PubMed ID: 29282688
[TBL] [Abstract][Full Text] [Related]
27. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
28. Dual action of cyclin-dependent kinase inhibitors: induction of cell cycle arrest and apoptosis. A comparison of the effects exerted by roscovitine and cisplatin.
Wesierska-Gadek J; Gueorguieva M; Horky M
Pol J Pharmacol; 2003; 55(5):895-902. PubMed ID: 14704484
[TBL] [Abstract][Full Text] [Related]
29. Targeting the cell cycle: a new approach to cancer therapy.
Schwartz GK; Shah MA
J Clin Oncol; 2005 Dec; 23(36):9408-21. PubMed ID: 16361640
[TBL] [Abstract][Full Text] [Related]
30. A novel targeted therapy in breast cancer: cyclin dependent kinase inhibitors.
Akin S; Babacan T; Sarici F; Altundag K
J BUON; 2014; 19(1):42-6. PubMed ID: 24659641
[TBL] [Abstract][Full Text] [Related]
31. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells.
Ahmad N; Adhami VM; Afaq F; Feyes DK; Mukhtar H
Clin Cancer Res; 2001 May; 7(5):1466-73. PubMed ID: 11350919
[TBL] [Abstract][Full Text] [Related]
34. Cell cycle machinery in oncology: A comprehensive review of therapeutic targets.
Cavalu S; Abdelhamid AM; Saber S; Elmorsy EA; Hamad RS; Abdel-Reheim MA; Yahya G; Salama MM
FASEB J; 2024 Jun; 38(11):e23734. PubMed ID: 38847486
[TBL] [Abstract][Full Text] [Related]
35. Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes.
Singh RP; Agarwal C; Agarwal R
Carcinogenesis; 2003 Mar; 24(3):555-63. PubMed ID: 12663518
[TBL] [Abstract][Full Text] [Related]
36. Cytometry of cyclin proteins.
Darzynkiewicz Z; Gong J; Juan G; Ardelt B; Traganos F
Cytometry; 1996 Sep; 25(1):1-13. PubMed ID: 8875049
[TBL] [Abstract][Full Text] [Related]
37. Cyclin-dependent kinase inhibitors: cancer killers to neuronal guardians.
Monaco EA; Vallano ML
Curr Med Chem; 2003 Mar; 10(5):367-79. PubMed ID: 12570697
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of CDKs as a therapeutic modality.
Sausville EA; Johnson J; Alley M; Zaharevitz D; Senderowicz AM
Ann N Y Acad Sci; 2000 Jun; 910():207-21; discussion 221-2. PubMed ID: 10911915
[TBL] [Abstract][Full Text] [Related]
39. Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.
Zabihi M; Lotfi R; Yousefi AM; Bashash D
J Cancer Res Clin Oncol; 2023 Apr; 149(4):1585-1606. PubMed ID: 35781526
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
